Type 1 diabetes

Comorbidity of Type 1 Diabetes and Attention-deficit Hyperactivity Disorder (ADHD): A Longitudinal Cohort Study in Males and Females From the Norwegian Childhood Diabetes Registry

Pediatr DiabetesPublished Longitudinal registry-based cohort study

Authors' conclusion

Mean national HbA1c decreased in Norway during the last decade, but continued to be higher in individuals with comorbid ADHD than in individuals with type 1 diabetes only.

Study context

Population
Individuals with T1D in the Norwegian Childhood Diabetes Registry (NCDR), 2005–2022; general paediatric population of Norway for ADHD medication prevalence
Participants
365 vs 5,888
Exposure
T1D with comorbid ADHD vs T1D only
  • Comorbid ADHDn = 365
  • T1D onlyn = 5,888reference
Outcome
Mean HbA1c, comorbid ADHD vs T1D only
Follow-up
2016 to 2022
Methodological detailsregister linkage, linear mixed-effects models adjusted for age and diabetes duration, Part 1: Norwegian Prescription Database and NCDR–Norwegian Prescribed Drug Registry linkage, 2005–2019; Part 2: NCDR annual controls, 2005–2022
  • Register linkage
  • Linear mixed-effects models adjusted for age and diabetes duration
  • Part 1: Norwegian Prescription Database and NCDR–Norwegian Prescribed Drug Registry linkage, 2005–2019; Part 2: NCDR annual controls, 2005–2022

Main finding

As reported in the abstract

  • Mean national HbA1c decreased from 2012 to 2022 but was higher with comorbid ADHD; difference significant from 2016 to 2022
  • Comorbid ADHD vs T1D only: 67.6 mmol/mol [8.3%] vs 64.5 mmol/mol [8.1%]; significant
  • Comorbid ADHD vs T1D only: 57.5 mmol/mol [7.4%] vs 54.7 mmol/mol [7.2%]; significant
  • Linear mixed-effects models adjusted for age and diabetes duration

Observational data: associations, not effects.

Further findings

OutcomeEstimate
≥1 episode of DKAComorbid ADHDvs T1D onlyOR 1.39 (95% CI 1.04–1.86)
≥1 episode of DKAComorbid ADHDvs T1D onlyOR, males 1.65 (95% CI 1.15–2.36)
≥1 episode of DKAComorbid ADHDvs T1D onlyOR, females 1.10 (95% CI 0.658–1.83)

Yearly prevalence of prescribed ADHD medications, NCDR vs general population · 2009-2019

Higher in NCDR than general population by (percentage points)
0.02 to 0.52
Difference significant only for 2017

Mean HbA1c by sex

Differences remained significant in males (except 2018), but not in females

Original publication

Comorbidity of Type 1 Diabetes and ADHD: A Longitudinal Cohort Study in Males and Females From the Norwegian Childhood Diabetes Registry. Pediatr Diabetes. Published 10 November 2025. doi:10.1155/pedi/9574797

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.